China’s approach to regulatory law has both helped and hindered the government’s response to COVID-19.
The United Kingdom’s lockdown measures prompt questions of its legality.
Israel’s executives have authority to combat COVID-19, but they appear to be abusing their power.
Italy’s early missteps in responding to the coronavirus can teach the world lessons on responding to pandemics.
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.
The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.
Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.
Scholar weighs the possibility of regulating medical artificial intelligence like human professionals.
New study shows regulators have overlooked insurers in tackling the opioid epidemic.
The Supreme Court declines to resolve issue of whether state hospitals can be sued for false insurance claims.
Controversial rule promotes personal care and bars forced arbitration in long-term health care.